175 related articles for article (PubMed ID: 31065617)
1. Cardiovascular Outcomes in Autonomous Cortisol Secretion and Nonfunctioning Adrenal Adenoma: A Systematic Review.
Park J; De Luca A; Dutton H; Malcolm JC; Doyle MA
J Endocr Soc; 2019 May; 3(5):996-1008. PubMed ID: 31065617
[TBL] [Abstract][Full Text] [Related]
2. Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?
Rebelo JFD; Costa JM; Junqueira FD; Fonseca AO; de Almeida ABABS; Moraes AB; Vieira Neto L
Clin Endocrinol (Oxf); 2023 May; 98(5):662-669. PubMed ID: 36514987
[TBL] [Abstract][Full Text] [Related]
3. Mortality in Patients With Nonfunctional Adrenal Tumors.
Patrova J; Mannheimer B; Lindh JD; Falhammar H
JAMA Intern Med; 2023 Aug; 183(8):832-838. PubMed ID: 37358871
[TBL] [Abstract][Full Text] [Related]
4. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
5. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow-up.
Ruiz A; Michalopoulou T; Megia A; Näf S; Simón-Muela I; Solano E; Martínez L; Vendrell J
Eur J Clin Invest; 2019 Feb; 49(2):e13048. PubMed ID: 30412278
[TBL] [Abstract][Full Text] [Related]
7. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
[TBL] [Abstract][Full Text] [Related]
8. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
Papanastasiou L; Alexandraki KI; Androulakis II; Fountoulakis S; Kounadi T; Markou A; Tsiavos V; Samara C; Papaioannou TG; Piaditis G; Kaltsas G
Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
[TBL] [Abstract][Full Text] [Related]
9. Nonfunctioning and Subclinical Cortisol Secreting Adrenal Incidentalomas and their Association with Metabolic Syndrome: A Systematic Review.
Khan U
Indian J Endocrinol Metab; 2019; 23(3):332-346. PubMed ID: 31641636
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas.
Yener S; Ertilav S; Secil M; Akinci B; Demir T; Kebapcilar L; Yesil S
Med Princ Pract; 2012; 21(5):429-34. PubMed ID: 22398948
[TBL] [Abstract][Full Text] [Related]
11. Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes.
Araujo-Castro M; Paja Fano M; Pla Peris B; González Boillos M; Pascual-Corrales E; García-Cano AM; Parra Ramírez P; Rojas-Marcos PM; Ruiz-Sanchez JG; Vicente A; Gómez-Hoyos E; Ferreira R; García Sanz I; Recasens M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo C; Manjón L; García-Centeno R; Percovich JC; Rebollo Román Á; Gracia Gimeno P; Robles Lázaro C; Morales M; Calatayud M; Collao SAF; Meneses D; Sampedro Nuñez MA; Escudero Quesada V; Ribas EM; Sanmartín Sánchez A; Diaz CG; Lamas C; Guerrero-Vázquez R; Del Castillo Tous M; Serrano J; Michalopoulou T; Moya Mateo EM; Hanzu F
Endocr Connect; 2023 Aug; 12(9):. PubMed ID: 37410097
[TBL] [Abstract][Full Text] [Related]
12. Autonomous cortisol secretion in adrenal incidentalomas.
Araujo-Castro M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Apr; 64(1):1-13. PubMed ID: 30847651
[TBL] [Abstract][Full Text] [Related]
13. Adrenal incidentaloma: a new cause of the metabolic syndrome?
Terzolo M; Pia A; Alì A; Osella G; Reimondo G; Bovio S; Daffara F; Procopio M; Paccotti P; Borretta G; Angeli A
J Clin Endocrinol Metab; 2002 Mar; 87(3):998-1003. PubMed ID: 11889151
[TBL] [Abstract][Full Text] [Related]
14. Adrenal Venous Sampling for Assessment of Autonomous Cortisol Secretion.
Ueland GÅ; Methlie P; Jøssang DE; Sagen JV; Viste K; Thordarson HB; Heie A; Grytaas M; Løvås K; Biermann M; Husebye ES
J Clin Endocrinol Metab; 2018 Dec; 103(12):4553-4560. PubMed ID: 30137397
[TBL] [Abstract][Full Text] [Related]
15. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
[TBL] [Abstract][Full Text] [Related]
16. Expression of adrenocorticotropin receptor gene in adrenocortical adenomas from patients with Cushing syndrome: possible contribution for the autonomous production of cortisol.
Imai T; Sarkar D; Shibata A; Funahashi H; Morita-Matsuyama T; Kikumori T; Ohmori S; Seo H
Ann Surg; 2001 Jul; 234(1):85-91. PubMed ID: 11420487
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]